ReviewInternational journal of nanomedicine2026
Ferroptosis-Like Death: An Emerging Innovative Antibacterial Strategy.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tissue-Resident Macrophages: Linking Physiology and Inflammation in Infection.Clinical reviews in allergy & immunology · 2026Review
- Liposome-Mediated Bacterial Ferroptosis-like Death: A Novel Paradigm for Antimicrobial Therapy.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing global crisis of antibiotic resistance underscores the imperative for innovative antibacterial strategies that transcend conventional mechanisms. Ferroptosis, an iron-dependent form of regulated cell death characterized by lethal lipid peroxidation, is a promising therapeutic approach. This review systematically explores ferroptosis-like death as an emerging antibacterial paradigm. The core mechanism involves exogenous interventions that result in intracellular iron overload, the incorporation of polyunsaturated fatty acids (PUFAs), and the disruption of bacterial antioxidant defenses. A comprehensive evaluation of three key strategies is provided: host-directed approach, in which immune cells are programmed to eliminate intracellular pathogens; small molecule-induced pathway, in which iron agents, PUFAs, and others are used to directly trigger bacterial death; and nanomaterial-mediated precision therapy, in which functionalized nanosystems are employed for synergistic and intelligent targeting. Despite the challenges in mechanistic understanding and biosafety, future advancements through multiomics, intelligent nanosystems, and synergistic cell death pathways are anticipated to propel this field. This strategy indicates a possible transformation in anti-infective therapy from broad-spectrum killing to precision regulation. This shift offers a potentially effective solution to address drug-resistant bacterial infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.